Author

Doll, Richard

Peto, Richard

Place of Publication

New York, NY

Publisher

Oxford University Press

Publication Date

1981

Subjects

Neoplasms - etiology

Neoplasms - prevention & control

Language

English

Material Type

Book

Audience

Professional

Location

Victoria Library

Call Number

QZ202 D665 1981

Copies

Alternate Title

EMF epidemiology

Corporate Author

National Radiological Protection Board

Editor

McKinlay, A.F

Repacholi, M.H.

Place of Publication

[United Kingdom]

Publisher

Nuclear Technology Publishing

Publication Date

1999

Physical Description

x, 194 p. :ill. ; 25 cm.

Series

Radiation protection dosimetry, Vol. 83: Nos. 1-2.

Subjects

Electromagnetic Fields - adverse effects

Neoplasms - etiology

Radiometry

Radiation Exposure - prevention & control

Radiation Dosage

Radiation Monitoring

Epidemiology

Congresses

ISBN

1870965612

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

QT34.8 R129 1999

Copies

Corporate Author

World Health Organization

Edition

2nd ed.

Place of Publication

Geneva

Publisher

World Health Organization

Publication Date

2002

Subjects

Neoplasms - prevention & control

National Health Programs

Health Policy

ISBN

9241545577

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

QZ200 N277 2002

Copies

Corporate Author

National Council on Radiation Protection and Measurements

Place of Publication

[Bethesda, MD]

Publisher

National Council on Radiation Protection and Measurements

Publication Date

2017

Physical Description

1 online resource

Series

Proquest Ebook Central

NCRP report 179

Subjects

Radiometry

Disaster Planning

Radiation Protection

Emergency Medical Services - organization & administration

Abstract

Table of Contents:

1. Executive Summary -- 2. Introduction -- 2.1 Scope -- 2.2 Report Goals -- 2.3 Framework -- 2.4 Emergency Workers -- 3. Dosimetry Needs and Key Concepts -- 3.1 Introduction -- 3.2 What is Dosimetry? -- 3.3 Dosimetry Programs -- 3.4 Dose of Record -- 3.5 Key Concepts -- 4. Methods of Dose Determination and Estimation: Operational -- 4.1 Framework and Situational Description -- 4.2 Measurements with Limited Resources -- 4.3 Categories of Radiation Equipment -- 4.3.1 Instrument Types -- 4.3.2 Instrument Radiological Quantities -- 4.3.3 Applicable ANSI Standards -- 4.3.4 Operational Ranges of Existing Equipment -- 4.4 Mission Applicability -- 4.4.1 Handheld Survey Meter -- 4.4.2 Aerial Measurements -- 4.4.3 Large Mobile and Transportable Radiation Detectors -- 4.4.4 Radiation Portal Monitors and Fixed Detector Networks -- 4.5 Data Aggregation -- 5. Recording, Tracking and Communicating Dosimetry Results -- 5.1 Emergency Worker Dosimetry Recordkeeping -- 5.2 Dose Tracking and Communication with the Incident Command System -- 5.3 Communicating Radiation Dose -- 5.3.1 Communicating Dose to Emergency Workers -- 5.3.2 Additional Audiences -- 5.3.3 Challenges in Communicating Radiation Dose -- 6. Recommendations for Response Organization's Radiological Capability -- 6.1 Objective -- 6.2 Capability Recommendations -- 6.2.1 Basic Level Capability -- 6.2.2 Intermediate Level Capability -- 6.2.3 Advanced Level Capability -- 6.3 On-Scene Functional Capability -- 7. Status of Emergency Workers with Regulations and Guidance -- 7.1 NRC Regulations -- 7.2 DOE Regulations -- 7.3 OSHA Regulations -- 7.4 EPA Regulations -- 7.5 PAG Manual -- 7.6 IAEA Guidance -- 7.7 Health Insurance Portability and Accountability Act and Emergency Worker Dosimetry -- 8. Data Needs for Dose Reconstruction -- 8.1 Dose Reconstruction

8.2 Fundamental Elements -- 8.2.1 Source Term -- 8.2.2 Environmental Transport -- 8.2.3 Receptor Definition -- 8.2.4 Exposure Scenario -- 8.2.5 Calculation of Dose -- 8.3 Key Issues -- 8.3.1 Dose Endpoint Identification -- 8.3.2 Model Domain -- 8.3.3 Data Sources -- 8.3.4 Uncertainty -- 8.3.5 Lessons from Previous Dose Reconstructions -- 9. Conclusion -- Appendix A. Units ConversionTable -- Appendix B. Excerpts from Previous NCRP Publications -- B.1 Report No. 138 (NCRP, 2001) -- B.2 Commentary No. 19 (NCRP, 2005) -- B.3 Report No. 165 (NCRP, 2010) -- Appendix C. Biodosimetry -- Appendix D. Example of a Robust Emergency Response Dosimetry Program -- D.1 Equipment -- D.1.1 Dosimeter Kit -- D.1.2 Dose Assessment Kit -- D.1.3 Surrogate Control Passive Dosimeter Kit -- D.2 Personnel and Procedures -- D.2.1 First Responding Personnel -- D.2.2 Dose Assessment Unit -- D.3 Challenges of a Robust Dosimetry Program -- D.4 Contingencies Jurisdictions -- Appendix E Placing Doses in Perspective -- Abbreviations and Acronyms -- Glossary -- References -- Scientific Committee and Staff -- The NCRP -- Officers -- Members.

Notes

Title page: Oct 2, 2017

ISBN

9780913392133

9780913392102

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Corporate Author

National Council on Radiation Protection and Measurements

Place of Publication

[Bethesda, MD]

Publisher

National Council on Radiation Protection and Measurements

Publication Date

2017

Physical Description

1 online resource

Series

Proquest Ebook Central

NCRP report 176

Subjects

Nanoparticles

Radiation Exposure - adverse effects

Radiation Protection - methods

Radiometry

Safety Management - methods

Nanotechnology - standards

United States

Guideline

Abstract

Table of Contents:

1. Executive Summary -- 1.1 Background -- 1.2 Scope -- 1.3 Conclusions and Recommendations -- 1.3.1 General -- 1.3.2 Operational Health Physics -- 1.3.3 Internal Dosimetry -- 1.3.4 Summary -- 2. Introduction -- 2.1 Background -- 2.2 Purpose -- 3. Types and Sources of Nanomaterials Including Radioactive Nanoparticles -- 3.1 Introduction -- 3.2 Naturally Occurring and Incidentally Produced Nanomaterials -- 3.3 Radiation-Induced Synthesis of Nanomaterials -- 3.4 Radioactive Nanomaterials -- 3.4.1 Naturally Occurring Radioactive Nanomaterials -- 3.4.2 Incidentally Produced Radioactive Nanomaterials -- 3.4.3 Radiolabeled Nanomaterials -- 4. Physicochemical Concerns for Exposure to Nanoparticles -- 4.1 Nanoparticle Physicochemical Properties -- 4.1.1 Deposition Within the Respiratory Tract -- 4.1.2 Translocation Across Organ Membranes -- 4.1.3 Surface Area and Reactivity in Biological Systems -- 4.1.4 Particle Shape -- 4.1.5 Particle Agglomeration -- 4.1.6 Material Dispersibility -- 4.1.7 Material Surface Charge -- 4.2 Nanoparticle Exposure Experiences Involving Humans -- 4.2.1 Magic Nano Event -- 4.2.2 Event in China -- 4.2.3 Nickel Sensitization Case -- 4.2.4 Polymer and Metal Fume Experience -- 4.3 Guidance on Managing Physicochemical Concerns for Exposure to Nanoparticles -- 5. Operational Health Physics in a Nanotechnology Environment -- 5.1 Introduction -- 5.1.1 Attention to the Physicochemical Toxicity of Radioactive Nanomaterials -- 5.1.2 Changes that May be Needed for Internal Dosimetry -- 5.1.3 Changes that May be Needed for Dispersion of Airborne Particles -- 5.1.4 Summary of Radiation Program Elements Applicable to Working with Radioactive Nanomaterials -- 5.2 Hierarchy of Exposure Controls for Facility and Process Design -- 5.2.1 Elimination and Substitution -- 5.2.2 Engineered Controls

5.2.3 Administrative Controls -- 5.2.4 Personal Protective Equipment -- 5.3 Use of Radioactive Nanomaterials in Medical Settings -- 5.4 Management and Disposal of Radioactive Nanomaterial Waste -- 5.5 Control of Public Exposure -- 5.6 Emergency Response -- 5.7 Incident Investigation -- 5.8 Effective Risk Communication -- 6. Nanoparticle Issues for Internal Radiation Dosimetry -- 6.1 Framework for Considering Radioactive Nanoparticle Internal Dosimetry -- 6.2 General Approach to Biokinetic Modeling for Intakes of Radioactive Nanoparticles -- 6.3 Radiation Dosimetry of Inhaled Radioactive Nanoparticles -- 6.3.1 Deposition of Inhaled Radioactive Nanoparticles -- 6.3.2 Clearance of Inhaled Radioactive Nanoparticles -- 6.3.3 Respiratory Tract Dosimetry for Radioactive Nanoparticles -- 6.4 Radiation Dosimetry of Ingested Radioactive Nanoparticles -- 6.5 Radiation Dosimetry of Radioactive Nanoparticles for Intact Skin -- 6.6 Radiation Dosimetry of Radioactive Nanoparticles in Wounds -- 6.7 Biokinetics of Nanoparticles that Affect Internal Dosimetry -- 6.7.1 Regional Deposition of Radioactive Nanoparticles -- 6.7.2 Biokinetic Characteristics of Inhaled Radioactive Nanoparticles -- 6.7.3 Biokinetics Example: Monomeric and Polymeric Plutonium -- 7. Dose Assessment and Medical Management for Individuals Exposed to Radioactive Nanoparticles -- 7.1 Approaches for Dose Assessment -- 7.2 Occupational Exposure and Dose Assessment Scenario: Plutonium Processing Facility -- 7.3 Impact of Radioactive Nanoparticles on Dose Assessment -- 7.4 Impact of Radioactive Nanoparticles on Medical Management Decisions -- 8. Conclusions and Recommendations -- 8.1 Hazard and Exposure Assessment -- 8.1.1 Conclusions -- 8.1.2 Recommendations -- 8.2 Operational Health Physics -- 8.2.1 Conclusions -- 8.2.2 Recommendations -- 8.3 Nanoparticle Issues for Radiation Dosimetry

8.3.1 Conclusions -- 8.3.2 Recommendations -- 8.4 Dose Assessment and Medical Management -- 8.4.1 Conclusions -- 8.4.2 Recommendations -- Appendix A. Radiolabeled Nanoparticles -- A.1 Use of Radionuclides to Characterize and Quantitate Nanoparticle Contents -- A.2 Radiolabeled Nanoparticles for Biokinetic and Toxicologic Investigations -- A.3 Radiolabeled Nanoparticles for Diagnostic Medicine -- A.4 Radiolabeled Nanoparticles for Medical Imaging -- A.5 Radiolabeled Nanoparticles for Therapeutic Medicine -- A.6 Use of Radiation-Induced Emissions and Hyperthermal Effects from Nanoparticles in Therapeutic Medicine -- Appendix B. Biokinetic Models -- B.1 Fate of Nanoparticles in the Lungs -- B.2 Particle Clearance and Translocation Pathways -- B.3 Exposure and Biokinetics of Ingested Nanoparticles -- B.4 Human and Animal Studies Using Radioactive Nanoparticles -- Appendix C. Key Concepts for Understanding Nanoparticle Aerosol Properties and Behaviors -- C.1 Introduction -- C.2 A Range of Mechanisms Influence Particle Motion and Collection -- C.3 Behavior of Airborne Nanoparticles is Dominated by Brownian Diffusion -- C.4 Particle Volume Equivalent Diameter, Thermodynamic Diameter, and Aerodynamic Equivalent Diameter are Related -- C.5 Particle Size Distributions are Frequently Lognormal -- C.6 Nanoparticles Dominate the Count Distribution -- C.7 Nanoparticles Exist to Some Extent in the Majority of Occupational Aerosols -- C.8 Smaller Particles have a Greater Fraction of Their Atoms at the Particle Surface -- C.9 Number Concentrations of Concern Depend on the Material of Concern -- C.10 Realistic Airborne Particle Number Concentrations can be Limited by Coagulation -- C.11 Smaller Particles are More Difficult to Dislodge from Surfaces than Larger Particles -- Abbreviations, Acronyms and Symbols -- Glossary -- References -- Scientific Committee and Staff

The NCRP -- Officers -- Members -- Distinguished Emeritus Members -- Lauriston S. Taylor Lectures -- Warren K. Sinclair Keynote Addresses -- Thomas S. Tenforde Topical Lectures -- NCRP Publications -- NCRP Reports -- NCRP Commentaries -- Proceedings of the Annual Meeting -- Lauriston S. Taylor Lectures -- Warren K. Sinclair Keynote Addresses -- Thomas S. Tenforde Topical Lectures -- Symposium Proceedings -- NCRP Statements -- Other Documents

Notes

Title page: March 2, 2017

ISBN

9780913392041

9780913392027

Language

English

Material Type

Ebook

Audience

Professional

Location

Internet

Website Notes

This Proquest title is licensed for ONE BC Cancer staff user at a time. If you are denied access while on a network computer, please try again later.

Authentication via HealthBC sign in required. Use your BC Cancer staff username and ID when prompted.

Alternate Title

National report : preliminary results from the 2009 cancer care survey.

Voice of experience

Corporate Author

Cancer Control Council of New Zealand

Place of Publication

Wellington, NZ

Publisher

Cancer Control Council of New Zealand

Publication Date

2009

Physical Description

42 p. : ill. ; 30 cm.

Subjects

Patient Reported Outcome Measures

Patient-Centered Care

Health Services - utilization

Delivery of Health Care

Neoplasms - therapy

Neoplasms - prevention & control

Health Care Surveys

Cancer Care Facilities

New Zealand

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

QZ200 C215v 2009

Copies

Editor

Hecht, Stephen S.

Hatsukami, Dorothy K.

Place of Publication

New Jersey

Publisher

World Scientific Publishing

Publication Date

[2022]

Physical Description

xxii, 427 p. : ill. ; 24 cm

Subjects

Neoplasms - prevention & control

Smoking

Tobacco - adverse effects

Smoking - adverse effects

Abstract

"This book tells the fascinating story of the relationship of tobacco products to cancer, from the first discoveries to the present day cancer pandemic and regulatory activities. Although there are already excellent books and monographs on this topic, both in the popular press and as government summaries, none relate the scientific story at the level of non-specialist graduate and medical students, researchers, or educated popular science readers. In this book, the editors bring together 24 renowned experts on the subject of tobacco and cancer to summarize specific aspects of this critical topic in relatively non-technical terms while also incorporating some personal insights related to the story of the discovery process"-- Provided by publisher

ISBN

9789811239526

Language

English

Material Type

Book

Audience

Professional

Location

Vancouver Library

Call Number

WA900 T628h 2022

Copies